NCT07180290

Brief Summary

A new psychotherapy has been developed within the Psychiatry, Sleep and Chronobiology Reference Center (ChronoS) since January 2022.Results have shown relevant clinical interest on insomnia symptoms, as well on mood, anxiety and hypervigilance, according to the observation of the center's team (nurses, psychologists, psychiatrists and somnologist) In order to evaluate the effectiveness of this psychotherapy, the investigators would like to carry a multimodal approach on the severity of insomnia in patients with mood disorders.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
67

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 30, 2023

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2024

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

January 31, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 30, 2025

Completed
6 months until next milestone

First Posted

Study publicly available on registry

September 18, 2025

Completed
Last Updated

September 18, 2025

Status Verified

September 1, 2025

Enrollment Period

1.7 years

First QC Date

January 31, 2025

Last Update Submit

September 15, 2025

Conditions

Keywords

InsomniaMood disorders

Outcome Measures

Primary Outcomes (1)

  • Insomnia Severity Index (ISI)

    brief self report questionnaire to assess the severity of insomnia cases

    Baseline visit : at participants' inclusion Visit 1: alongside 1st session of the therapy Visit 2: after the 4th session of the therapy Visit 3: after the last session (8th) of the therapy Visit 4 : 3 months after the end of the therapy

Secondary Outcomes (19)

  • Seasonal Pattern Assessment Questionnaire (SPAQ)

    Baseline visit : at participants' inclusion Visit 1: alongside 1st session of the therapy Visit 2: after the 4th session of the therapy Visit 3: after the last session (8th) of the therapy Visit 4 : 3 months after the end of the therapy

  • Morningness-Eveningness Questionnaire (MEQ)

    Baseline visit : at participants' inclusion Visit 1: alongside 1st session of the therapy Visit 2: after the 4th session of the therapy Visit 3: after the last session (8th) of the therapy Visit 4 : 3 months after the end of the therapy

  • The Berlin Questionnaire

    Baseline visit : at participants' inclusion Visit 1: alongside 1st session of the therapy Visit 2: after the 4th session of the therapy Visit 3: after the last session (8th) of the therapy Visit 4 : 3 months after the end of the therapy

  • Pittsburgh Sleep Quality Index

    Baseline visit : at participants' inclusion Visit 1: alongside 1st session of the therapy Visit 2: after the 4th session of the therapy Visit 3: after the last session (8th) of the therapy Visit 4 : 3 months after the end of the therapy

  • The Epworth Sleepiness Scale (ESS)

    Baseline visit : at participants' inclusion Visit 1: alongside 1st session of the therapy Visit 2: after the 4th session of the therapy Visit 3: after the last session (8th) of the therapy Visit 4 : 3 months after the end of the therapy

  • +14 more secondary outcomes

Study Arms (2)

Bipolar disorder

EXPERIMENTAL

Bipolar disorder is defined by the DSM-5 as the experience of episodes of depression or anhedonia (i.e., a lack of interest or pleasure in activities) and at least four additional symptoms: decreased energy; psychomotor slowing or psychomotor restlessness; changes in appetite and weight; sleep disturbance (from insomnia to hypersomnia); difficulty concentrating and/or inability to make everyday decisions; feelings of worthlessness and/or excessive guilt; and suicidal ideation and attempts.

Behavioral: Psychotherapy

Unipolar disorder

EXPERIMENTAL

Unipolar disorder is defined by the DSM-5 as the experience of 5 or more of the following symptoms, at least once per day, and for a period that's longer than 2 weeks: * Sadness or irritability, lasting most of the day * Loss of interest in the majority of activities that were enjoyable before * Change in appetite, or sudden weight loss/gain * Difficulty falling asleep, or wanting to sleep more than before * Feelings of restlessness * Lack of energy and increased tiredness * Feelings of worthlessness or guilt, often linking to things that normally wouldn't have this kind of effect * Difficulty concentrating, making decisions and thinking * Suicidal or self-harming thoughts

Behavioral: Psychotherapy

Interventions

PsychotherapyBEHAVIORAL

Session 1 : Introduction and awareness of the sleep-wake link Session 2 : Awareness of day/night habits and behaviors Session 3 : Awareness of sleep/wake rhythms and sleepiness signals Session 4 : Awareness of the night/bed/sleep association Session 5 : Awareness of emotions and thoughts related to sleep Session 6 : Awareness of possible alternatives Session 7 : Awareness of one's relationship to sleep Session 8 : Awareness of future benefits

Bipolar disorderUnipolar disorder

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged over 18 years old
  • Diagnosed with
  • A mood disorder (bipolar or unipolar) recognized in the DSM-5
  • Chronic insomnia disorder recognized in the DSM-5
  • Must have obtained a score ≥ 8 on the ISI scale evaluated by the clinician, that indicates at least an insomnia of mild intensity

You may not qualify if:

  • Patients aged under 18 years old
  • Patients with psychotic disorder
  • Patients who have previously undergone CBT insomnia or other targeted cognitive behavioral therapy
  • Patients under guardianship, curatorship or protection of the court

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre CHRONOS

Paris, France

Location

MeSH Terms

Conditions

Sleep Initiation and Maintenance DisordersMood Disorders

Interventions

Psychotherapy

Condition Hierarchy (Ancestors)

Sleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesMental Disorders

Intervention Hierarchy (Ancestors)

Behavioral Disciplines and Activities

Study Officials

  • Pierre-Alexis GEOFFROY, Professor of psychiatry

    GHU Paris Psychiatrie et Neurosciences

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 31, 2025

First Posted

September 18, 2025

Study Start

April 30, 2023

Primary Completion

December 30, 2024

Study Completion

March 30, 2025

Last Updated

September 18, 2025

Record last verified: 2025-09

Locations